KLHL14 and adenocarcinoma: Regarding the distribution, KLHL14 mutations were mainly (10% of the cases) found in adenomas and adenocarcinomas, followed by lymphoma (8.51% of the cases) and melanoma (5.96% of the cases) (Figure 1A).